U.S. Markets closed

Migraine-Focused Biotech Has A Headache On Quarterly Losses

Migraine-Focused Biotech Has A Headache On Quarterly Losses

Biohaven Pharmaceutical slumped to a three-week low Wednesday after the biotech reported greater-than-expected third-quarter losses.